Blog
New FDA Approach to Drug Prices Adds Uncertainty to Drug Approval Process
In the first year of the second Trump administration, we have seen the Food and Drug Administration (FDA) take an unprecedented role in drug pricing policy….
By: Skadden, Arps, Slate, Meagher & Flom LLP